ATE132862T1 - Aryl- und heteroaryl-piperazinylcarboxamide mit wirkung auf das zentrale nervensystem - Google Patents
Aryl- und heteroaryl-piperazinylcarboxamide mit wirkung auf das zentrale nervensystemInfo
- Publication number
- ATE132862T1 ATE132862T1 AT89305255T AT89305255T ATE132862T1 AT E132862 T1 ATE132862 T1 AT E132862T1 AT 89305255 T AT89305255 T AT 89305255T AT 89305255 T AT89305255 T AT 89305255T AT E132862 T1 ATE132862 T1 AT E132862T1
- Authority
- AT
- Austria
- Prior art keywords
- nervous system
- central nervous
- piperazinylcarboxamide
- heteroaryl
- aryl
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title abstract 2
- -1 1-adamantyl Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19789088A | 1988-05-24 | 1988-05-24 | |
| US29746089A | 1989-01-13 | 1989-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE132862T1 true ATE132862T1 (de) | 1996-01-15 |
Family
ID=26893250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89305255T ATE132862T1 (de) | 1988-05-24 | 1989-05-24 | Aryl- und heteroaryl-piperazinylcarboxamide mit wirkung auf das zentrale nervensystem |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0343961B1 (de) |
| JP (1) | JP2711284B2 (de) |
| KR (1) | KR0128345B1 (de) |
| AT (1) | ATE132862T1 (de) |
| AU (1) | AU628341B2 (de) |
| CA (1) | CA1340113C (de) |
| DE (1) | DE68925385T2 (de) |
| DK (1) | DK168665B1 (de) |
| ES (1) | ES2081302T3 (de) |
| FI (1) | FI94130C (de) |
| GB (1) | GB2218988B (de) |
| GR (1) | GR3019217T3 (de) |
| HU (1) | HU205923B (de) |
| IE (1) | IE64151B1 (de) |
| IL (1) | IL90279A (de) |
| NZ (1) | NZ229225A (de) |
| PT (1) | PT90633B (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
| US5254552A (en) * | 1988-05-24 | 1993-10-19 | American Home Products Corporation | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
| US5278160A (en) * | 1988-05-24 | 1994-01-11 | American Home Products Corporation | Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders |
| ES2027898A6 (es) * | 1991-01-24 | 1992-06-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina. |
| US5225412A (en) * | 1991-04-29 | 1993-07-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
| US5143923B1 (en) * | 1991-04-29 | 1993-11-02 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
| JP3136206B2 (ja) * | 1991-10-22 | 2001-02-19 | 中外製薬株式会社 | ベンゾジオキサン誘導体 |
| GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
| IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
| US5474994A (en) * | 1992-05-26 | 1995-12-12 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A |
| ES2046107B1 (es) * | 1992-03-05 | 1994-08-01 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina. |
| SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
| IT1258315B (it) * | 1992-04-10 | 1996-02-22 | Recordati Chem Pharm | Derivati del flavone |
| JP3062249B2 (ja) * | 1993-06-25 | 2000-07-10 | ポーラ化成工業株式会社 | ドーパミン再取込み阻害剤 |
| US5395835A (en) * | 1994-03-24 | 1995-03-07 | Warner-Lambert Company | Naphthalamides as central nervous system agents |
| US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| US5486518A (en) * | 1995-04-10 | 1996-01-23 | American Home Products Corporation | 4-indolylpiperazinyl derivatives |
| US5519025A (en) * | 1995-04-10 | 1996-05-21 | American Home Products Corporation | 4-indolylpiperazinyl derivatives |
| AU2393997A (en) | 1996-04-05 | 1997-10-29 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Alpha1-adrenergic receptor antagonists |
| US5860391A (en) * | 1996-08-06 | 1999-01-19 | First Brands Corporation | Absorbents containing activated carbons |
| US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
| IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| AUPP891299A0 (en) * | 1999-02-26 | 1999-03-25 | Fujisawa Pharmaceutical Co., Ltd. | New 6-membered cyclic compounds |
| US6664293B2 (en) | 1999-02-26 | 2003-12-16 | Fujiwawa Pharmaceutical Co., Ltd. | Amide compounds for the potentiation of cholinergic activity |
| US6306859B1 (en) | 1999-03-02 | 2001-10-23 | American Home Products Corporation | N-substituted imide derivatives with serotonergic activity |
| HK1042090A1 (zh) * | 1999-03-02 | 2002-08-02 | Wyeth | N-取代的具有5-羟色胺能活性的酰亚胺衍生物 |
| BR0015539A (pt) * | 1999-11-12 | 2002-07-16 | Wyeth Corp | Adamantil e noradamantil aril- e aralquilpiperazinas ramificadas com atividade 5-ht1a de serotonina |
| US6831084B1 (en) | 1999-11-12 | 2004-12-14 | Wyeth | Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity |
| JP2005531571A (ja) * | 2002-05-23 | 2005-10-20 | アボット・ラボラトリーズ | 性機能不全の治療に有用なアセトアミド類およびベンズアミド類 |
| KR20050075281A (ko) * | 2002-07-04 | 2005-07-20 | 쉬바르츠파르마에이지 | 씨엔에스 질병의 치료를 위한 도파민-디3 리간드로서헤테로아렌 카복스아미드의 용도 |
| DE10232020A1 (de) | 2002-07-04 | 2004-02-26 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Neurorezeptoraktive Heteroarencarboxamide |
| DE102004054634A1 (de) * | 2004-11-12 | 2006-05-18 | Schwarz Pharma Ag | Azaindolcarboxamide |
| DE102004063797A1 (de) * | 2004-12-30 | 2006-07-13 | Schwarz Pharma Ag | Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide |
| MX2008002014A (es) * | 2005-08-15 | 2008-03-27 | Hoffmann La Roche | Derivados de piperidina y piperazina como antagonistas de p2x3. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3734915A (en) * | 1970-02-02 | 1973-05-22 | American Cyanamid Co | N-(-(4-phenyl-1-piperazinyl)alkyl)benzo(b)thiophene or benzofuran-2-carboxamides |
| US3646047A (en) * | 1970-02-02 | 1972-02-29 | American Cyanamid Co | Certain benzo(b)thiophene-2-carboxamide derivatives |
| US4001223A (en) * | 1975-01-13 | 1977-01-04 | Idemitsu Kosan Co., Ltd. | Adamantane-piperazine derivatives |
| DE3304019A1 (de) * | 1983-02-07 | 1984-08-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 3-acyloxy-1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| AU577802B2 (en) * | 1983-10-17 | 1988-10-06 | Duphar International Research B.V. | Blood-pressure lowering piperazine derivatives |
-
1989
- 1989-05-12 IL IL9027989A patent/IL90279A/en not_active IP Right Cessation
- 1989-05-12 CA CA000599685A patent/CA1340113C/en not_active Expired - Fee Related
- 1989-05-18 HU HU892488A patent/HU205923B/hu not_active IP Right Cessation
- 1989-05-19 FI FI892424A patent/FI94130C/fi not_active IP Right Cessation
- 1989-05-22 NZ NZ229225A patent/NZ229225A/en unknown
- 1989-05-22 AU AU35025/89A patent/AU628341B2/en not_active Ceased
- 1989-05-23 PT PT90633A patent/PT90633B/pt active IP Right Grant
- 1989-05-23 IE IE166289A patent/IE64151B1/en not_active IP Right Cessation
- 1989-05-23 DK DK249989A patent/DK168665B1/da not_active IP Right Cessation
- 1989-05-23 KR KR1019890006857A patent/KR0128345B1/ko not_active Expired - Fee Related
- 1989-05-23 JP JP1129975A patent/JP2711284B2/ja not_active Expired - Lifetime
- 1989-05-24 EP EP89305255A patent/EP0343961B1/de not_active Expired - Lifetime
- 1989-05-24 ES ES89305255T patent/ES2081302T3/es not_active Expired - Lifetime
- 1989-05-24 AT AT89305255T patent/ATE132862T1/de not_active IP Right Cessation
- 1989-05-24 GB GB8911912A patent/GB2218988B/en not_active Expired - Lifetime
- 1989-05-24 DE DE68925385T patent/DE68925385T2/de not_active Expired - Lifetime
-
1996
- 1996-03-05 GR GR960400623T patent/GR3019217T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR900018049A (ko) | 1990-12-20 |
| DK249989A (da) | 1989-11-25 |
| HU205923B (en) | 1992-07-28 |
| DE68925385D1 (de) | 1996-02-22 |
| EP0343961A3 (de) | 1991-01-16 |
| PT90633A (pt) | 1989-11-30 |
| IE891662L (en) | 1989-11-24 |
| GB8911912D0 (en) | 1989-07-12 |
| DE68925385T2 (de) | 1996-05-15 |
| DK168665B1 (da) | 1994-05-16 |
| GB2218988B (en) | 1991-12-18 |
| GB2218988A (en) | 1989-11-29 |
| FI94130B (fi) | 1995-04-13 |
| EP0343961B1 (de) | 1996-01-10 |
| JPH0215059A (ja) | 1990-01-18 |
| AU3502589A (en) | 1989-11-30 |
| NZ229225A (en) | 1990-12-21 |
| FI94130C (fi) | 1995-07-25 |
| GR3019217T3 (en) | 1996-06-30 |
| KR0128345B1 (ko) | 1998-04-03 |
| HUT53095A (en) | 1990-09-28 |
| AU628341B2 (en) | 1992-09-17 |
| IL90279A (en) | 1995-03-30 |
| IL90279A0 (en) | 1989-12-15 |
| JP2711284B2 (ja) | 1998-02-10 |
| IE64151B1 (en) | 1995-07-12 |
| FI892424L (fi) | 1989-11-25 |
| PT90633B (pt) | 1994-11-30 |
| CA1340113C (en) | 1998-11-03 |
| ES2081302T3 (es) | 1996-03-01 |
| EP0343961A2 (de) | 1989-11-29 |
| DK249989D0 (da) | 1989-05-23 |
| FI892424A0 (fi) | 1989-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE132862T1 (de) | Aryl- und heteroaryl-piperazinylcarboxamide mit wirkung auf das zentrale nervensystem | |
| EP0256503A3 (en) | Pyridinecarboxamide derivatives and their use as fungicide | |
| FI874115A0 (fi) | Foerfarande foer framstaellning av etynylfenylhaltiga retinolsyraderivat. | |
| DE19775022I2 (de) | Hetroaromatische und heterobicyclische Gruppen enthaltende disubstituierte Acetylene mit retinoidaehnlicher Wirkung | |
| PL292101A1 (en) | Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine | |
| DE69529418D1 (de) | Cyclopropachromencarbonsäure derivate | |
| ES538418A0 (es) | Un derivado de indol-3-carboxamida | |
| CS89587A2 (en) | Zpusob vyroby arylcyklobutylalkylaminu | |
| NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
| ATE122669T1 (de) | Zearalanol-derivate mit anabolytischer wirkung. | |
| KR900014345A (ko) | 대뇌 신경 전달계 질병 치료제 | |
| FR2572074B1 (fr) | Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant | |
| PT85300A (fr) | Procede de preparation de nouveaux derives de la piperazine dione-2,6 | |
| ATE115582T1 (de) | Cephalosporinderivate. | |
| DE68921673D1 (de) | 3-Deoxymycaminosyltylonolidderivate. | |
| ATE189813T1 (de) | Prostaglandin-i-analoga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |